Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA location entry for Zaporizhzhya, Ukraine, 69600 was added and the Zaporizhzhia, Ukraine, 69600 entry was removed to correct the city spelling in the site listings. The page revision was updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a version bump in the page's content management. This change does not modify study data or public study details.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of v3.6.0, indicating a newer revision of the page/document.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page gains new helper sections for reading the study record, joining the study, and answering common questions, and the recruitment status is updated to indicate no active enrollment; the revision label is updated to v3.6.0 and the Intervention/Treatment heading formatting is adjusted.SummaryDifference0.3%

- Check58 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, marking a new version of the ClinicalTrials.gov study record.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.